Cell and Gene Therapy
Mycenax offers a comprehensive, one-stop CDMO service covering a broad spectrum of Allogeneic Cell and Gene Therapy (CGT) Products. We are committed to delivering total solutions that facilitate process development and GMP manufacturing of innovative CGT products, enabling our clients to expedite their products to market through our state-of-the-art, scalable closed-process platforms featuring automated and modular workflows. Mycenax's highlighted solutions include the provision of streamlined allogeneic cell sources as starting materials, ensuring our clients embark on their product development journey with the right cells. |
||||||||||
|
||||||||||
Mycenax's Technology Platforms for Diverse Allogeneic CGT Products
|
||||||||||
|
||||||||||
OUR STRATEGIC PARTNERSHIPS
StemCyte supplies cell therapy materials for Mycenax’s global allogeneic cell therapy CDMO business. Mycenax and StemCyte announce a collaboration to strengthen their one-stop service chain for allogeneic cell therapy – read our press release.
|
||||||||||
Keyword: Cell therapy, CGT, cell and gene therapy, gene therapy, 3D process, immune cell, NK cell, GDT cell, MSC, CDMO, CMO, GMP manufacturing |
Mycenax offers a comprehensive, one-stop CDMO service covering a broad spectrum of Allogeneic Cell and Gene Therapy (CGT) Products. We are committed to delivering total solutions that facilitate process development and GMP manufacturing of innovative CGT products, enabling our clients to expedite their products to market through our state-of-the-art, scalable closed-process platforms featuring automated and modular workflows. Mycenax's highlighted solutions include the provision of streamlined allogeneic cell sources as starting materials, ensuring our clients embark on their product development journey with the right cells. |
||||||||||
|
||||||||||
Mycenax's Technology Platforms for Diverse Allogeneic CGT Products
|
||||||||||
|
||||||||||
OUR STRATEGIC PARTNERSHIPS
StemCyte supplies cell therapy materials for Mycenax’s global allogeneic cell therapy CDMO business. Mycenax and StemCyte announce a collaboration to strengthen their one-stop service chain for allogeneic cell therapy – read our press release.
|
||||||||||
Keyword: Cell therapy, CGT, cell and gene therapy, gene therapy, 3D process, immune cell, NK cell, GDT cell, MSC, CDMO, CMO, GMP manufacturing |